lifestyle.newsblaze.com

Author: Harbour Biomed

Harbour BioMed Appoints Dr. Adam Zong as President

April 16, 2026
Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth

March 30, 2026
Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody

March 22, 2026
Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation

March 19, 2026
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis

March 9, 2026
Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results

February 3, 2026
Nona Biosciences Co-founds Innovative Alliance for Translational Medicine in Immunological Diseases, Advancing a New IIT-Driven Ecosystem

January 28, 2026
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration

January 18, 2026
Nona Biosciences Enters into Collaboration Agreement with Link Cell Therapies to Advance CAR-T Cell Therapies

January 9, 2026
Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates

December 28, 2025